Reported anecdotal side effects from non-clinical use have been minimal, typically limited to mild injection site reactions
It is directly recognized by the body and immediately available without any conversion steps
Hillman L, Gottfried M, Whitsett M, Rakela J, Schilsky M, Lee WM, Ganger D
The main findings highlight that high-dose EPA substantially reduced migraine frequency and severity, improved psychological symptoms, and enhanced the quality of life for episodic migraine patients, suggesting its potential as an effective prophylactic, particularly for female patients
Current studies have revealed a strong link between ferroptosis and the GSH system, which has become a hotspot in the field of CVDs